Skip to main content
MGX logo

MGX · Metagenomi Therapeutics, Inc.

$1.24 +0.00 (+0.00%) At close · Jul 17
Market Cap
$46.68M
Shares
37,646,858

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 49
Total Value: $8,747,594
Total Shares: 6,536,147

Institutional Ownership Trend

10 quarters

Holder Concentration

Across 48 13F filers
Top Holder
16.4%
Mar 2024 → Mar 2026 · range 13.5% – 20.7%
of institutional value
Top 5
52.4%
Mar 2024 → Mar 2026 · range 48.0% – 54.7%
of institutional value
Top 10
77.6%
Mar 2024 → Mar 2026 · range 68.9% – 77.6%
of institutional value
HHI
779
Mar 2024 → Mar 2026 · range 641 – 826
Broadly held
Showing 49 of 49
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1785279 CUSIP 59102M104 13F (30d) 1 filings 1 filers Visit website Investor relations